APA
Hutson P. H., Finger E. N., Magliaro B. C., Smith S. M., Converso A., Sanderson P. E., Mullins D., Hyde L. A., Eschle B. K., Turnbull Z., Sloan H., Guzzi M., Zhang X., Wang A., Rindgen D., Mazzola R., Vivian J. A., Eddins D., Uslaner J. M., Bednar R., Gambone C., Le-Mair W., Marino M. J., Sachs N., Xu G. & Parmentier-Batteur S. (20120525). The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology.
Chicago
Hutson P H, Finger E N, Magliaro B C, Smith S M, Converso A, Sanderson P E, Mullins D, Hyde L A, Eschle B K, Turnbull Z, Sloan H, Guzzi M, Zhang X, Wang A, Rindgen D, Mazzola R, Vivian J A, Eddins D, Uslaner J M, Bednar R, Gambone C, Le-Mair W, Marino M J, Sachs N, Xu G and Parmentier-Batteur S. 20120525. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology.
Harvard
Hutson P. H., Finger E. N., Magliaro B. C., Smith S. M., Converso A., Sanderson P. E., Mullins D., Hyde L. A., Eschle B. K., Turnbull Z., Sloan H., Guzzi M., Zhang X., Wang A., Rindgen D., Mazzola R., Vivian J. A., Eddins D., Uslaner J. M., Bednar R., Gambone C., Le-Mair W., Marino M. J., Sachs N., Xu G. and Parmentier-Batteur S. (20120525). The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology.
MLA
Hutson P H, Finger E N, Magliaro B C, Smith S M, Converso A, Sanderson P E, Mullins D, Hyde L A, Eschle B K, Turnbull Z, Sloan H, Guzzi M, Zhang X, Wang A, Rindgen D, Mazzola R, Vivian J A, Eddins D, Uslaner J M, Bednar R, Gambone C, Le-Mair W, Marino M J, Sachs N, Xu G and Parmentier-Batteur S. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology. 20120525.